RheumConnect - Sunshine Rheumatology Review


Thank you for participating in the ARTHROS RheumConnect Sunshine Rheumatology Review in Ft. Lauderdale, FL!  The RheumConnect regional series will employ a multi-faceted approach for delivering content using didactic and performance-based active learning. The focus will be on new concepts regarding disease etiology, clinical presentation, phenotype, and emerging therapies.

Please select “Register/Take Course” to complete the following:

  • Pre-test

  • Post-test

  • Program evaluation

Upon completion, you will receive your accreditation certificate. 

The pre-test will close on Saturday, December 3 at 10:00 AM EST.

The post-program activities will become available on Saturday, December 3 at 3:00 PM EST.



  • If you already have a profile, please sign in and select Take Course.
  • First-time users will be asked to “register” for the platform by creating a profile/account.
    • When accessing the platform, select Register to set up your online profile.
    • You will need to create a username (your email) and password to set up a short profile within the platform before gaining access.
    • While completing your profile, please enter your license number in the Board Certification & Licensure section (if applicable):
      • Nursing license number
      • National Association of Boards of Pharmacy (NABP) number
      • American Board of Internal Medicine’s (ABIM) number

Target Audience

This initiative is designed for rheumatology clinicians and health care professionals who treat rheumatic disease.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Review data on the prevalence of rheumatic diseases
  • Describe the progressive nature and detrimental effects of untreated rheumatic diseases
  • Discuss updates in diagnosis, classification and treatment guidelines and demonstrate strategies to incorporate these guidelines into practice
  • Analyze recently approved and emerging treatment options, including a review of their safety and efficacy through analysis of how new agents are improving patient care
  • Identify and analyze any "hot topics" in specific areas of rheumatic disease (such as the use of biosimilars, new treatments for psoriatic disease, vasculitis, gout, and drugs in development)
Course summary
Available credit: 
  • 5.00 AMA PRA Category 1 Credit
  • 5.00 AMA PRA Category 1 Credit™ (Non- MD)
Course opens: 
Course expires: 

ACCME Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Purdue University College of Pharmacy and Focus Medical Communications. Purdue University College of Pharmacy, an equal access/equal opportunity institution, is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

Purdue University College of Pharmacy designates this live activity for a maximum of 5.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure/Conflict of Interest Policy

To ensure compliance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, Purdue University requires that all individuals in a position to control the content of an educational activity disclose all financial relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant conflicts of interest identified are thoroughly assessed by Purdue University to ensure fair balance, scientific rigor, and accepted patient care recommendations of the educational activity.

All relevant conflicts of interest have been mitigated prior to the start of the activity.

None of the planners, reviewers, Focus Medical Communications staff, and Purdue University College of Pharmacy staff have relevant financial relationship(s) with ineligible companies to disclose unless listed below.


Supported by an educational grant from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.

Available Credit

  • 5.00 AMA PRA Category 1 Credit
  • 5.00 AMA PRA Category 1 Credit™ (Non- MD)
Please login or register to take this course.